SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals surges as its Panelav facility gets VAI from USFDA

04 May 2020 Evaluate
Alembic Pharmaceuticals is currently trading at Rs. 765.55, up by 19.60 points or 2.69% from its previous closing of Rs. 745.95 on the BSE.

The scrip opened at Rs. 746.00 and has touched a high and low of Rs. 775.00 and Rs. 732.00 respectively. So far 10883 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 840.95 on 28-Apr-2020 and a 52 week low of Rs. 435.10 on 21-Jun-2019.

Last one week high and low of the scrip stood at Rs. 840.95 and Rs. 729.20 respectively. The current market cap of the company is Rs. 14525.15 crore.

The promoters holding in the company stood at 72.97%, while Institutions and Non-Institutions held 15.96% and 11.07% respectively.

The US Food & Drug Administration (USFDA) has classified the Alembic Pharmaceuticals’ General Oral Solid Formulation Facility located at Panelav as Voluntary Action Indicated (VAI). Inspection at the said facility was conducted by USFDA from March 09, 2020 to March 13, 2020.
 
VAI means USFDA accepted the company’s response to its observations.
 
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

785.40 8.05 (1.04%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×